Home
News
Create
Screeners
Insights
Sanjivani Paranteral
208.
00
-0.85
(-0.41%)
Market Cap
₹255.50 Cr
PE Ratio
31.52
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-0.41%
1M
-6.75%
6M
-10.73%
1Y
-32.69%
5Y
+2,141.38%
View Company Insights
Latest news about Sanjivani Paranteral
Sanjivani Parenteral Limited Initiates Postal Ballot for Director Appointment
4 days ago
Sanjivani Parenteral Limited has initiated a postal ballot to appoint Mr. Basant Shrivastava as a Non-Executive Independent Director for a 5-year term starting September 11, 2025. Mr. Shrivastava, 69, brings over 40 years of pharmaceutical industry experience. E-voting will run from November 5 to December 4, 2025, with results expected by December 6. The Board of Directors recommends shareholders approve this appointment as an Ordinary Resolution.
Sanjivani Paranteral Appoints Pharma Veteran Basant Shrivastava as Independent Director
Sep 11, 2025
Sanjivani Parenteral Launches Commercial Production at New IV Fluid Plant in Pune
Sep 08, 2025
Sanjivani Parenteral Reports 8.9% Revenue Growth in Q1, Pune Facility Set for Commercial Production
Aug 18, 2025
Sanjivani Paranteral Reports 8.9% Revenue Growth in Q1 FY26, Driven by Strong Injectables Performance
Aug 12, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation